These conflicting reports may reflect the differences in mRNA vs. protein analysis, considering that Nrf2 is tightly regulated at the post-translational level, as well as the heterogeneity of HCC samples. This evidence concerns the gene NFE2L2 and hepatocellular carcinoma.